US Patent 7794715 Anti-TIRC7 antibodies in therapy of inflammatory diseases
Patent 7794715 was granted and assigned to CellAct Pharma GmbH on September, 2010 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7794715 Anti-TIRC7 antibodies in therapy of inflammatory diseases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
